95,075 total recalls in our database
Panaderia Salvadorena Ii
Product contains undeclared milk.
Undeclared peanuts, soy, sesame, and wheat.
Potential Foreign material (plastic)
TONY'S CHOCOLONELY
Contains foreign objects (stones)
DELICIAS DE LA ABUELA
Undeclared allergen: Soy lecithin, less than 2%
Duda Farm Fresh Foods
Product tested positive for Listeria Monocytogenes.
TONY'S CHOCOLONELY
Contains foreign objects (stones)
Lins Waha International
Contains Cyclamates
La Mexicana Tortilla Factory
Undeclared Yellow #5
Tristar Food Wholesale Co
Product contains cyclamates
Label declares tahini paste but does not declare sesame.
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA Recommended Intake Limit
The Harvard Drug Group LLC
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
MEDLINE INDUSTRIES, LP - Northfield
There is a potential for open/weak seals on purchased breather pouches used for packaging of select sterile convenience kits.
Abbott Diagnostics Scarborough
the impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.
Lack of sterility assurance for closed suction catheter systems
Tandem Diabetes Care
A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.